421Cardiovascular Morbidity Following Definitive Chemoradiotherapy for Lung Cancer in an Appalachian Population.2026 · Europe PMC
423Blueprint for adapting the cardiac rehabilitation model for oncology patients with cardiovascular-kidney-metabolic syndrome.2026 · Europe PMC
424Immune Checkpoint Inhibitor-Associated Cardiovascular Toxicity in Melanoma: Current Evidence and Practical Clinical Management.2026 · Europe PMC
425Cardiac Troponin Elevation Beyond Type 1 Myocardial Infarction: A Systematic Review of Prognostic Significance and Cardiovascular Risk Stratification.2026 · Europe PMC
426Rapid Treatment of Acute Decompensated Heart Failure with Cardiogenic Shock in the Emergency Setting.2026 · Europe PMC
427Association of Aspirin Use with In-Hospital Mortality in Patients with Radiation-Associated Acute Pneumonitis: Insights from the National Inpatient Sample Database.2026 · Europe PMC
428Cardio-oncology in multidisciplinary synergy: addressing the rising burden of cancer therapy-related cardiovascular toxicity (CTR-CVT) in advancing oncology practices.2026 · Europe PMC
429Effect of Yoga on inflammatory markers and its impact on cardiovascular health and rehabilitation: A systematic review.2026 · Europe PMC
430Evaluation of Early Diagnostic Methods for Subclinical Cardiovascular Changes in Childhood Obesity.2026 · Europe PMC
431Cardiovascular Diseases in the Critically Ill: Bridging Evidence Gaps Between Cardiology and Intensive Care Medicine.2026 · Europe PMC
432Sildenafil Positivity and Chronic Cardiac Pathology in Men Who Died of Ischemic Heart Disease: An Age- and Sex-Matched Postmortem Case-Control Study.2026 · Europe PMC
433Tracing the evolution of cardiology: Pioneering discoveries and paradigm shifts in cardiovascular care.2026 · Europe PMC
434Pericoronary adipose tissue imaging: quantitative assessment, artificial intelligence integration, and therapeutic modulation.2026 · Europe PMC
435Coronary Artery Disease in Women: Sex-Specific Pathophysiology, Risk Factors, Clinical Presentation and Management.2026 · Europe PMC
436Regulatory mechanisms and interactions of mitophagy and ketone body metabolism in cardiac metabolism.2026 · Europe PMC
437MicroRNAs and SGLT2 inhibitors in cardiovascular disease: Shared pathways and emerging roles.2026 · Europe PMC
438Cardiovascular Diseases: Exploring Epidemiology, Pathophysiology, Risk Factors, and Medicinal Plant-Based Therapies: A Narrative Review.2026 · Europe PMC
439Regional cardiac 31 P-MRSI at 7T: detection of spatially heterogeneous patterns of myocardial energetic impairment2026 · Europe PMC
442Hauora Manawa mō ngā Kaumātua me ngā Whānau: a co-designed community-based cohort study of cardiovascular health among older Māori in Canterbury, New Zealand-a study protocol.2026 · Europe PMC
443Rationale and design of the PREGnancy, HEART Health and Cardiovascular Disease (PREG-HEART) Cohort Study2026 · Europe PMC
444Sports Cardiology: From Diagnosis to Clinical Management-Towards Individualized Cardiovascular Care Through Exercise.2026 · Europe PMC
445Reversing the pipeline: a 'human-first' multi-omics approach to cardiovascular discovery.2026 · Europe PMC
446Pyroptosis in cardiovascular diseases: A bibliometric insight into current research and future directions.2026 · Europe PMC
447Cardiovascular Complications Associated with Uro-Oncology Treatments-A Primer for the Clinician.2026 · Europe PMC
448Intestinal Flora and Myocarditis: Potential Mechanisms and Therapeutic Strategies Affecting Disease Progression and Cardiac Function.2026 · Europe PMC
449Update in Perioperative Ischemic Workup: Integrating 2024 AHA/ACC Guidelines and Contemporary Evidence.2026 · Europe PMC
451Role of Cardiac Imaging in the Evaluation of Rheumatoid Arthiritis: A Systematic Analysis.2026 · Europe PMC
452The emerging potential of the psycho-cardiovascular interaction network in precision medicine.2026 · Europe PMC
454Advancing precision cardio-oncology: multimodal surveillance and stratified management of immunotherapy-induced cardiovascular toxicity.2026 · Europe PMC
455Advances in cardiovascular risk assessment indicators in obstructive sleep apnea.2026 · Europe PMC
456Safety and efficacy of ivabradine in the treatment of patients with acute myocardial infarction: a real-world propensity score matching study.2026 · Europe PMC
457Beyond Hyperglycemia: The Role of Sodium-Glucose Cotransporter 2 Inhibitors in Cancer Treatment-related Cardiac Dysfunction.2026 · Europe PMC
458Balancing Oncological Care and Quality of Life: Diagnostic and Therapeutic Strategies for Chemotherapy-Induced Cardiotoxicity-A Narrative Review.2026 · Europe PMC
460Cardiotoxicity of Immune Checkpoint Inhibitors and Chimeric Antigen Receptor T-Cell Therapy.2026 · Europe PMC
463Rethinking Secondary Cardiovascular Prevention in the Digital Era: Patient Empowerment, Adherence and Optimisation of Guideline-based Care.2026 · Europe PMC
464Emerging Prognostic Risk Factors in Acute Coronary Syndromes: Beyond Traditional Risk Assessment.2026 · Europe PMC
465Post-Traumatic Stress Disorder and Atherosclerosis: Co-Phenomena, or Cause-and-Effect?2026 · Europe PMC
466Perimenopause as a potential window of cardiometabolic remodeling in heart failure with preserved ejection fraction: a missed opportunity for prevention.2026 · Europe PMC
467Risk factors for carfilzomib-related cardiovascular adverse events in Chinese patients with multiple myeloma: A real-world retrospective cohort study.2026 · Europe PMC
468Endocrine crosstalk in cardiovascular-kidney-metabolic syndrome-related heart failure: the fibroblast growth factor 23-Klotho axis and cardiometabolic therapy.2026 · Europe PMC
469Cardiovascular outcomes associated With GLP-1 and dual GLP-1/GIP receptor agonists in patients with type 2 diabetes and inflammatory bowel disease: A retrospective real-world cohort study.2026 · Europe PMC
470Clinician and Patient Perspectives on Cardiac Rehabilitation for Type 1 vs Type 2 Myocardial Infarction.2026 · Europe PMC
471Assessment of Wrist-Worn Activity Tracker Accuracy for Measuring Sedentary Behavior in Outpatients With Cardiovascular Disease: Validation Study.2026 · Europe PMC
473Role of a Heart Center for Women in the Prevention and Diagnosis of Atherosclerotic Cardiovascular Disease in Women.2026 · Europe PMC
474Incidence and Associated Risk Factors in the Development of Carfilzomib-Induced Cardiovascular Toxicity.2026 · Europe PMC
476NLRP3-mediated pyroptosis in cardiovascular disease: from molecular mechanisms to therapeutic targets2026 · Europe PMC
477Current Clinical Treatments and Challenges for Cardiovascular Diseases: From Therapeutic Expansion to Individualized Care.2026 · Europe PMC
478The Cardio-Renal-Hepatic Axis in MASLD. Role of BDNF, NGF, and Metabolic Cross-Talk.2026 · Europe PMC
479Coronary artery calcium score-emerging role for opportunistic screening on thoracic CT and novel applications.2026 · Europe PMC
480Discrepancies in low-value practices across cardiovascular disease prevention guidelines. A narrative review.2026 · Europe PMC